Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/33514
Title: | The role of lung volume recruitment therapy in neuromuscular disease: a narrative review. | Austin Authors: | Sheers, Nicole L;O'Sullivan, Rachel;Howard, Mark E ;Berlowitz, David J | Affiliation: | Respiratory and Sleep Medicine Department of Physiotherapy, Christchurch Hospital, Canterbury, New Zealand. Institute for Breathing and Sleep Department of Physiotherapy, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC, Australia. Physiotherapy |
Issue Date: | 26-Jul-2023 | Date: | 2023 | Publication information: | Frontiers in Rehabilitation Sciences 2023; 4 | Abstract: | Respiratory muscle weakness results in substantial discomfort, disability, and ultimately death in many neuromuscular diseases. Respiratory system impairment manifests as shallow breathing, poor cough and associated difficulty clearing mucus, respiratory tract infections, hypoventilation, sleep-disordered breathing, and chronic ventilatory failure. Ventilatory support (i.e., non-invasive ventilation) is an established and key treatment for the latter. As survival outcomes improve for people living with many neuromuscular diseases, there is a shift towards more proactive and preventative chronic disease multidisciplinary care models that aim to manage symptoms, improve morbidity, and reduce mortality. Clinical care guidelines typically recommend therapies to improve cough effectiveness and mobilise mucus, with the aim of averting acute respiratory compromise or respiratory tract infections. Moreover, preventing recurrent infective episodes may prevent secondary parenchymal pathology and further lung function decline. Regular use of techniques that augment lung volume has similarly been recommended (volume recruitment). It has been speculated that enhancing lung inflation in people with respiratory muscle weakness when well may improve respiratory system "flexibility", mitigate restrictive chest wall disease, and slow lung volume decline. Unfortunately, clinical care guidelines are based largely on clinical rationale and consensus opinion rather than level A evidence. This narrative review outlines the physiological changes that occur in people with neuromuscular disease and how these changes impact on breathing, cough, and respiratory tract infections. The biological rationale for lung volume recruitment is provided, and the clinical trials that examine the immediate, short-term, and longer-term outcomes of lung volume recruitment in paediatric and adult neuromuscular diseases are presented and the results synthesised. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/33514 | DOI: | 10.3389/fresc.2023.1164628 | ORCID: | Journal: | Frontiers in Rehabilitation Sciences | Start page: | 1164628 | PubMed URL: | 37565183 | ISSN: | 2673-6861 | Type: | Journal Article | Subjects: | amyotrophic lateral sclerosis breath stacking insufflation lung inflation lung volume recruitment muscular dystrophy neuromuscular disease |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.